| Antibiotic penetration into bone and joints: an updated review AK Thabit, DF Fatani, MS Bamakhrama, OA Barnawi, LO Basudan, ... International journal of infectious diseases 81, 128-136, 2019 | 258 | 2019 |
| Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials AK Thabit, JL Crandon, DP Nicolau Expert opinion on pharmacotherapy 16 (2), 159-177, 2015 | 207 | 2015 |
| The ERACE-PA Global Surveillance Program: ceftolozane/tazobactam and ceftazidime/avibactam in vitro activity against a global collection of carbapenem-resistant Pseudomonas … CM Gill, E Aktaþ, W Alfouzan, L Bourassa, A Brink, CAD Burnham, ... European journal of clinical microbiology & infectious diseases 40, 2533-2541, 2021 | 55 | 2021 |
| Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogens AK Thabit, JL Crandon, DP Nicolau International journal of antimicrobial agents 48 (5), 535-541, 2016 | 50 | 2016 |
| Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms ML Monogue, AK Thabit, Y Hamada, DP Nicolau Antimicrobial agents and chemotherapy 60 (8), 5001-5005, 2016 | 43 | 2016 |
| Effect of simvastatin and atorvastatin on serum vitamin d and bone mineral density in hypercholesterolemic patients: a cross-sectional study A K Thabit, A Alhifany, R Alsheikh, S Namnqani, A Al-Mohammadi, ... Journal of Osteoporosis 2014, 2014 | 31 | 2014 |
| Assessment of Clostridium difficile Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin ST Housman, AK Thabit, JL Kuti, R Quintiliani, DP Nicolau infection control & hospital epidemiology 37 (2), 215-218, 2016 | 29 | 2016 |
| Eravacycline Pharmacokinetics and Challenges in Defining Humanized Exposure In Vivo AK Thabit, ML Monogue, DP Nicolau Antimicrobial agents and chemotherapy 60 (8), 5072-5075, 2016 | 27 | 2016 |
| Antibiotics in the biliary tract: a review of the pharmacokinetics and clinical outcomes of antibiotics penetrating the bile and gallbladder wall AK Thabit Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (7 …, 2020 | 25 | 2020 |
| Impact of vancomycin faecal concentrations on clinical and microbiological outcomes in Clostridium difficile infection AK Thabit, DP Nicolau International journal of antimicrobial agents 46 (2), 205-208, 2015 | 22 | 2015 |
| Incidence of Clostridioides difficile infection at a Saudi Tertiary Academic Medical Center and compliance with IDSA/SHEA, ACG, and ESCMID guidelines for treatment over a 10 … NA Aljafel, HH Al-Shaikhy, MA Alnahdi, AK Thabit Journal of Infection and Public Health 13 (8), 1156-1160, 2020 | 21 | 2020 |
| Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria Pseudomonas aeruginosa, Proteus mirabilis, and … AK Thabit, K Eljaaly, A Zawawi, TS Ibrahim, AG Eissa, SS Elbaramawi, ... Biology 11 (9), 1349, 2022 | 20 | 2022 |
| The pharmacodynamics of prolonged infusion β-lactams for the treatment of Pseudomonas aeruginosa infections: a systematic review AK Thabit, ALV Hobbs, OE Guzman, KM Shea Clinical Therapeutics 41 (11), 2397-2415. e8, 2019 | 20 | 2019 |
| Multidrug-resistant Pseudomonas aeruginosa infection in a child with cystic fibrosis JY Ang, N Abdel-Haq, F Zhu, AK Thabit, DP Nicolau, MJ Satlin, ... Antimicrobial Agents and Chemotherapy 60 (10), 5627-5630, 2016 | 20 | 2016 |
| Silencing of Salmonella typhimurium Pathogenesis: Atenolol Acquires Efficient Anti-Virulence Activities AK Thabit, K Eljaaly, A Zawawi, TS Ibrahim, AG Eissa, SS Elbaramawi, ... Microorganisms 10 (10), 1976, 2022 | 18 | 2022 |
| Lack of correlation of Brucella antibody titers with clinical outcomes and culture positivity of brucellosis SA Alsubaie, SA Turkistani, AA Zeaiter, AK Thabit Tropical Diseases, Travel Medicine and Vaccines 7, 1-7, 2021 | 18 | 2021 |
| Clinical impact of pharmacist-directed antimicrobial stewardship guidance following blood culture rapid diagnostic testing AJ Mahrous, AK Thabit, S Elarabi, J Fleisher Journal of Hospital Infection 106 (3), 436-446, 2020 | 18 | 2020 |
| Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic/pharmacodynamic … AK Thabit, ML Monogue, JV Newman, DP Nicolau International Journal of Antimicrobial Agents 51 (5), 727-732, 2018 | 18 | 2018 |
| A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin AK Thabit, MJ Alam, M Khaleduzzaman, KW Garey, DP Nicolau Annals of Clinical Microbiology and Antimicrobials 15, 1-7, 2016 | 16 | 2016 |
| Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against Salmonella enterica MA Elfaky, AK Thabit, K Eljaaly, A Zawawi, AS Abdelkhalek, AJ Almalki, ... Antibiotics 11 (11), 1585, 2022 | 13 | 2022 |
